Sol_75N98026Q00811.pdf

REQUEST FOR QUOTATION

(THIS IS NOT AN ORDER)

THIS RFQ IS IS NOT A SMALL BUSINESS SET-ASIDE

15. DATE OF QUOTATION

16. SIGNER

a. NAME (Type or print)

c. TITLE (Type or print)

b. TELEPHONE

AREA CODE

NUMBER

STANDARD FORM 18 (REV. 6/1995)

Prescribed by GSA-FAR (48 CFR) 53.215-1(a)

AUTHORIZED FOR LOCAL REPRODUCTION

Previous edition not usable

8. TO:

b. COMPANYa. NAME

c. STREET ADDRESS

d. CITY e. STATE f. ZIP CODE

9. DESTINATION

a. NAME OF CONSIGNEE

b. STREET ADDRESS

d. STATE e. ZIP CODE

7. DELIVERY

FOB DESTINATION

OTHER

(See Schedule)

10. PLEASE FURNISH QUOTATIONS TO THE

ISSUING OFFICE IN BLOCK 5a ON OR BEFORE CLOSE OF BUSINESS (Date)

IMPORTANT: This is a request for information and quotations furnished are not offers. If you are unable to quote, please so indicate on this form and return it to the address in Block 5a. This request does not commit the Government to pay any costs incurred in the preparation of the submission of this quotation or to contract for supplies or service. Supplies are of domestic origin unless otherwise indicated by quoter. Any representations and/or certifications attached to this Request for Quotation must be completed by the quoter.

11. SCHEDULE (Include applicable Federal, State and local taxes)

ITEM NUMBER

(a)

SUPPLIES/SERVICES

(b)

QUANTITY

(c)

UNIT

(d)

UNIT PRICE

(e)

AMOUNT

(f)

12. DISCOUNT FOR PROMPT PAYMENT

a. 10 CALENDAR DAYS (%) b. 20 CALENDAR DAYS (%) c. 30 CALENDAR DAYS (%) d. CALENDAR DAYS

NUMBER PERCENTAGE

NOTE: Additional provisions and representations are are not attached.

13. NAME AND ADDRESS OF QUOTER

a. NAME OF QUOTER

b. STREET ADDRESS

c. COUNTY

d. CITY e. STATE f. ZIP CODE

14. SIGNATURE OF PERSON AUTHORIZED TO

SIGN QUOTATION

PAGE OF PAGES

1. REQUEST NUMBER 2. DATE ISSUED 3. REQUISITION/PURCHASE REQUEST NUMBER 4. CERT. FOR NAT. DEF.

UNDER BDSA REG. 2

AND/OR DMS REG. 1

RATING

5a. ISSUED BY 6. DELIVER BY (Date)

NAME TELEPHONE NUMBER

AREA CODE NUMBER

c. CITY

5b. FOR INFORMATION CALL (NO COLLECT CALLS)

National Institutes of Health OD - Office of Logistics and Acquisition Operations 6100 Executive Blvd., Room 6B05 Bethesda, MD 20892-7511

75N98026Q00811

JOHN JOHNSON

+10

000-000000

07/15/2026

07/20/2026 1400 ED

Multiple

The purpose of this COMPETITIVE COMBINED

SYNOPSIS/SOLICITATION is to acquire a

TapeStation 4150 Instrument for NIDA.

The following FAR clauses and Provisions are applicable to this award.

FAR 52.204-13 System for Award

Management Maintenance (Oct 2018)

FAR 52.204-18 Commercial and Government

Entity Code Maintenance (Aug 2020)

HHSAR 352.222-70, Contractor Cooperation in Equal Employment Opportunity

Investigations (Dec 2015)

FAR 52.212-4 Contract Terms and

Conditions -In addition to all the

Continued...

1 2

CONTINUATION SHEET

REFERENCE NO. OF DOCUMENT BEING CONTINUED PAGES

NAME OF OFFEROR OR CONTRACTOR

SUPPLIES/SERVICES

(B)

UNIT

(D)

UNIT PRICE

(E)

AMOUNT

(F)

OPTIONAL FORM 336 (4-86)

Sponsored by GSA FAR (48 CFR) 53.110

ITEM NO.

(A)

QUANTITY

(C)

NSN 7540-01-152-8067

75N98026Q00811 applicable commercial Products and Commercial

Services (Nov 2023)

FAR 52.217-8 Option to Extend Services (Nov

1999)

FAR 52.252-2 CLAUSES INCORPORATED BY REFERENCE

COMBINED SYNOPSIS / SOLICITATION (COMPETITIVE)

Title: Pipetting Robot for Translational Analytical Core

(i) This is a combined synopsis/solicitation for commercial items prepared in accordance with FAR Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested, and a separate written solicitation will not be issued.

(ii) The solicitation number is 75N98026Q00811 /PCA-NIDCR-06746. This solicitation is issued as a competitive combined synopsis/solicitation for commercial products or commercial services. The Government intends to award a contract or purchase order resulting from this solicitation using full and open competition.

This acquisition is conducted under the authority of FAR 12.603, Streamlined Solicitation for Commercial Products or Commercial Services, and is not expected to exceed the simplified acquisition threshold.

The National Institutes of Health (NIH), Office of the Director, Office of Acquisitions, seeks to award a firm fixed-price award to the responsible offeror whose proposal represents the best value to the Government.

(iii) The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular March 2026.

(iv) The associated NAICS code is 334516, and the small business size standard is “Other Than Small Business”

• This requirement is NOT set aside for Small Business

(v) Description of Requirement:

(1) 4150 TapeStation instrument including software, vortexer, accessories, plastic consumables, user information and I+F. Does not include ScreenTape consumables and reagents. QTY 1.

(2) RNA ScreenTape, part of the TapeStation systems. QTY 1.

(3) RNA ScreenTape Sample Buffer, part of the TapeStation systems. QTY 1.

(4) RNA ScreenTape Ladder, part of the TapeStation systems. QTY 1.

(vi) Delivery Location:

NIH/NIDA

251 Bayview Blvd STE 200

BRC Bldg. RM 06A406

Baltimore, MD 21224

(vii) [Reserved, if needed]

(viii) FAR 52.204-7, System for Award Management, applies to this acquisition.

(ix) The provision at FAR 52.212-1, Instructions to Offerors—Commercial Items, applies to this acquisition. Add any agency-specific instructions as required.

(x) The provision at FAR 52.212-2, Evaluation—Commercial Items, applies to this acquisition.

(a) The Government will award a contract resulting from this solicitation to the responsible offeror whose offer conforming to the solicitation represents the best value to the Government, price and other factors considered.

(b) Evaluation Factors:

• Price

• Technical capability

• Past performance

• Delivery schedule

(c) A written notice of award or acceptance of an offer, issued within the time specified in the offer, shall result in a binding contract without further action by either party. The Government reserves the right to accept any offer before the expiration date.

(xi) FAR 52.212-4, Contract Terms and Conditions—Commercial Items, applies to this acquisition.

(xii) Additional contract requirements or terms and conditions, as determined necessary by the Contracting Officer and consistent with customary commercial practices:

(None)

(xiii) The Defense Priorities and Allocations System (DPAS) is (not applicable).

(xiv) Submission Requirements:

Responses must include sufficient information to demonstrate the offeror’s capability to provide the required product or service. Quotes shall include, at a minimum:

• Unit and total price

• Shipping and handling costs

• Delivery timeframe after award

• Delivery terms

• F.O.B. point (destination or origin)

• Product or catalog numbers (if applicable)

• Product/service description

Additional evaluation considerations may include past performance, warranty, lifecycle cost, maintenance availability, and environmental or energy efficiency.

Responses must include the Unique Entity Identifier (UEI), Taxpayer Identification Number (TIN), and business size certification. All offerors must be actively registered in the System for Award Management (SAM) at www.sam.gov.

All responses must be received by (July 20, 2026, and 2PM, EST) and must reference solicitation number 75N98026Q00811 /PCA-NIDCR-06746. Responses may be submitted electronically to johnsonjr@mail.nih.gov.

(xv) Point of Contact:

John Johnson, Program Specialist, johnsonjr@mail.nih.gov 667-312-5580.

mailto:johnsonjr@mail.nih.gov mailto:johnsonjr@mail.nih.gov

Version 11-30-2016-1 FAR Part 11—Describing Agency Needs

PURCHASE DESCRIPTION

1. Statement of Need and Purpose:

The NIDA IRP Cellular Stress and Inflammation (CSI) is looking to procure a TapeStation for automated quality control of RNA and DNA samples. CSI was established for the purpose of studying the role of endoplasmic reticulum (ER) stress and inflammation in neuronal dysfunction caused by substance abuse or neurodegenerative diseases. The Agilent 4150 TapeStation would provide rapid, highly reproducible quality control of RNA and DNA which is an essential requirement for accurately profiling stress- and inflammation-related gene expression.

2. Background Information and Objective: The NIDA IRP Mission is to conduct state-of-the-art basic, preclinical and clinical research on mechanisms that underlie substance use disorders, addiction and relapse. Ultimately we hope to translate these efforts into new methods for the prevention and treatment of substance use disorders highlighting the following: enhancing our research by taking advantage of our unique and outstanding strengths; increasing translational research and fortifying our clinical portfolio; strengthening our basic science with investment in technology; increasing Diversity and Inclusion at all levels; and prioritizing Trans-NIH initiatives and growing strong ties with other institutes. CSI would like to acquire the Agilent 4150 TapeStation to achieve automated electrophoresis with RINe scoring and DV200 metrics. This would allow researchers to quickly assess RNA integrity, detect degradation associated with cellular stress, and standardize sample quality across conditions. Its ability to quantify nucleic acids and resolve fragment size distributions using minimal sample volumes is particularly valuable when working with limited neuronal or glial samples. Additionally, the system’s fast throughput, internal normalization, and user-independent operation reduce variability and turnaround time, enabling more reliable comparisons of inflammatory signaling pathways and stress responses across experiments.

3. Name of Product: TapeStation 4150 Instrument

4. Purchase Description:

(1) G2992AA - 4150 TapeStation instrument including software, vortexer, accessories, plastic consumables, user information and I+F. Does not include ScreenTape consumables and reagents, (2) 5067-5576 - RNA ScreenTape, part of the TapeStation systems, (3) 5067-5577 - RNA ScreenTape Sample Buffer, part of the TapeStation systems, (4) 5067-5578 - RNA ScreenTape Ladder, part of the TapeStation systems

Salient characteristics

• Must have fluorescent detection

• Must use microfludic tape

• Must be able to process up to 16 samples per run

• Must provide quality control metrics for RNA and DNA

• Must provide software for instrument control and data analysis

• Must provide automated sample handling

Technical Characteristics Physical Specifications Weight: 17.8 kg (39.2 lbs) Dimensions (w×d×h): 254 x 510 x 417 mm (9.6 x 20.1 x 16.4 inches) Line voltage: 100 – 240 VAC ± 10 % Line frequency: 50 or 60 Hz ± 5 % Power consumption: 50 VA Interface: USB (Instrument: USB-B; PC: USB-A) Ambient operating temperature: 10 – 40 °C (50 – 104 °F) Operating humidity: 15 – 80 %, non-condensing Storage temperature: -40 to 70 °C (-40 to 158 °F) Operating altitude: Up to 3000 m (9842 ft) Safety standards IEC, EN, CSA, UL, Overvoltage category II, Pollution degree 2 For indoor use only.

ISM Classification: ISM Group 1 Class A According to CISPR 11 Sound pressure: <70 dB (A) According to ISO 7779:1988/EN 27779/1991 Assay specific temperature range:

12 – 37 °C (54 – 99 °F) for D1000 ScreenTape 17 – 37 °C (63 – 99 °F) for High Sensitivity D1000 ScreenTape 15 – 30 °C (59 – 86 °F) for Genomic DNA ScreenTape 14 – 30 °C (57 – 86 °F) for RNA and High Sensitivity RNA ScreenTape 15 – 30 °C (59 – 86 °F) for D5000 ScreenTape 15 – 30 °C (59 – 86 °F) for High Sensitivity D5000 ScreenTape 16 – 30 °C (61 – 86 °F) for Cell-free DNA ScreenTape

5. Quantity:

(1) 4150 TapeStation instrument including software, vortexer, accessories, plastic consumables, user information and I+F. Does not include ScreenTape consumables and reagents 1.00

(2) RNA ScreenTape, part of the TapeStation systems 1.00

(3) RNA ScreenTape Sample Buffer, part of the TapeStation systems 1.00

(4) RNA ScreenTape Ladder, part of the TapeStation systems 1.00

6. Delivery Date:

Desired delivery date is 5 weeks of receipt of order.

7. Period of Performance:

The warranty period for standard instruments is twelve (12) months from the date of acceptance. Consumables are warranted for ninety (90) days from the date of acceptance. Customer may receive a different warranty when the product is purchased as a part of a system. Selected Automation consumables are warranted for one hundred and eighty (180) days, selected Vacuum Products are warranted for twenty-four (24) months.

8. Option(s): Annual preventative maintenance can be exercised for up to 3 years.

Title